Atlas Trials

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

Clinical trial NCT00529802 · COMPLETED

Trial details

NCT number
NCT00529802
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Start date
2007-09-01
Primary completion
2010-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.